Attainment of therapeutic vancomycin level within the first 24 h.
作者信息
Honore Patrick M, De Bels David, Attou Rachid, Redant Sebastien, Gallerani Andrea, Kashani Kianoush
机构信息
ICU Department, Centre Hospitalier Universitaire Brugmann, Brugmann University Hospital, 4 Place Arthur Van Gehuchten, 1020, Brussels, Belgium.
Division of Nephrology and Hypertension, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, USA.
出版信息
Crit Care. 2019 Jun 21;23(1):228. doi: 10.1186/s13054-019-2515-5.
Abstract
摘要
相似文献
1
Attainment of therapeutic vancomycin level within the first 24 h.
Crit Care. 2019 Jun 21;23(1):228. doi: 10.1186/s13054-019-2515-5.
2
Attainment of therapeutic vancomycin level within the first 24 h: Authors' response.在最初24小时内达到治疗性万古霉素血药浓度：作者回复
Crit Care. 2019 Nov 13;23(1):354. doi: 10.1186/s13054-019-2639-7.
3
Optimal dose of vancomycin for treating methicillin-resistant Staphylococcus aureus pneumonia in critically ill patients.治疗重症患者耐甲氧西林金黄色葡萄球菌肺炎的万古霉素最佳剂量
Anaesth Intensive Care. 2011 Nov;39(6):1030-7. doi: 10.1177/0310057X1103900608.
4
Effect of vancomycin-coated tympanostomy tubes on methicillin-resistant Staphylococcus aureus biofilm formation: in vitro study.万古霉素涂层鼓膜造孔管对耐甲氧西林金黄色葡萄球菌生物膜形成的影响：体外研究
J Laryngol Otol. 2010 Jun;124(6):594-8. doi: 10.1017/S0022215109992672. Epub 2010 Jan 8.
5
Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus.头孢洛林、达巴万星、达托霉素、替加环素、利奈唑胺和万古霉素对重症监护病房分离的耐甲氧西林金黄色葡萄球菌的药效学蒙特卡洛模拟分析
Clin Exp Pharmacol Physiol. 2014 Jun;41(6):437-43. doi: 10.1111/1440-1681.12195.
6
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches.耐甲氧西林金黄色葡萄球菌引起的菌血症：新的治疗方法
Infect Dis Clin North Am. 2016 Jun;30(2):491-507. doi: 10.1016/j.idc.2016.02.009.
7
Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus using an in vitro model.头孢洛林的药效学活性对比社区获得性和医疗机构获得性耐甲氧西林金黄色葡萄球菌、异质性万古霉素中介金黄色葡萄球菌、万古霉素中介金黄色葡萄球菌和万古霉素耐药金黄色葡萄球菌，采用的是体外模型。
J Antimicrob Chemother. 2011 Jun;66(6):1301-5. doi: 10.1093/jac/dkr110. Epub 2011 Mar 23.
8
Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.使用体外模型比较头孢比普与万古霉素对耐甲氧西林金黄色葡萄球菌（MRSA）、万古霉素中介金黄色葡萄球菌（VISA）和耐万古霉素金黄色葡萄球菌（VRSA）的药效学活性。
J Antimicrob Chemother. 2009 Aug;64(2):364-9. doi: 10.1093/jac/dkp176. Epub 2009 May 19.
9
Emergence of vancomycin-intermediate and -resistant Staphylococcus aureus among methicillin-resistant S. aureus isolated from clinical specimens in the northwest of Iran.伊朗西北部从临床标本中分离出的耐甲氧西林金黄色葡萄球菌中出现了万古霉素中介和耐药金黄色葡萄球菌。
J Glob Antimicrob Resist. 2018 Sep;14:4-9. doi: 10.1016/j.jgar.2018.01.017. Epub 2018 Feb 14.
10
Optimum initial loading dose of vancomycin for pneumonia caused by methicillin-resistant Staphylococcus aureus.
J Infect. 2016 Jan;72(1):115-8. doi: 10.1016/j.jinf.2015.09.010. Epub 2015 Sep 28.
引用本文的文献
1
Genetic Algorithms as a Tool for Dosing Guideline Optimization: Application to Intermittent Infusion Dosing for Vancomycin in Adults.遗传算法作为剂量指南优化的工具：在成人万古霉素间歇性输注中的应用。
CPT Pharmacometrics Syst Pharmacol. 2020 May;9(5):294-302. doi: 10.1002/psp4.12512. Epub 2020 May 19.
2
Attainment of therapeutic vancomycin level within the first 24 h: Authors' response.在最初24小时内达到治疗性万古霉素血药浓度：作者回复
Crit Care. 2019 Nov 13;23(1):354. doi: 10.1186/s13054-019-2639-7.
本文引用的文献
1
New Regimen for Continuous Infusion of Vancomycin in Critically Ill Patients.危重症患者万古霉素持续输注的新方案
Antimicrob Agents Chemother. 2016 Jul 22;60(8):4750-6. doi: 10.1128/AAC.00330-16. Print 2016 Aug.
2
Decreasing the time to achieve therapeutic vancomycin concentrations in critically ill patients: developing and testing of a dosing nomogram.缩短重症患者达到万古霉素治疗浓度的时间：剂量校正图的制定与验证
Crit Care. 2014 Dec 5;18(6):654. doi: 10.1186/s13054-014-0654-2.
3
A new regimen for continuous infusion of vancomycin during continuous renal replacement therapy.一种在持续肾脏替代治疗期间持续输注万古霉素的新方案。
J Antimicrob Chemother. 2013 Dec;68(12):2859-65. doi: 10.1093/jac/dkt261. Epub 2013 Jun 25.
4
Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy.增强型肾清除率是接受抗菌治疗的危重症患者的常见现象，与更差的临床结局相关。
J Crit Care. 2013 Oct;28(5):695-700. doi: 10.1016/j.jcrc.2013.03.003. Epub 2013 May 14.
5
Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens.重症患者万古霉素剂量：改进连续输注方案的有力方法。
Antimicrob Agents Chemother. 2011 Jun;55(6):2704-9. doi: 10.1128/AAC.01708-10. Epub 2011 Mar 14.
Zotero 插件